IMDX NASDAQ
Credit Risk of going bust: higher than 68% of companies Debt: 2.6% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.02 (down 99.5%), Insight Molecular Diagnostics Inc. would be worth roughly what it owes.
Total debt $2.6M against a stock market value of $98.2M.
Distance to default 3.54 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $1.3M (short-term plus half of long-term), stock volatility 108.7%; Altman Z'' -55.49. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Nashville, TN 37217
US
OncoCyte Corporation functions as a molecular diagnostics firm specializing in the research, development, and market introduction of distinctive, laboratory-developed tests aimed at cancer identification. Its operations span both the United States and international territories. The company's key offerings include DetermaRx, a molecular diagnostic tool tailored for detecting early-stage adenocarcinoma of the lung, and DetermaIO, a proprietary gene expression analysis. Additionally, OncoCyte provides a range of expert services, such as biomarker discovery, assay design and refinement, and clinical trial assistance, which encompass offering various biomarker tests to pharmaceutical partners. A strategic partnership with Life Technologies Corporation focuses on the collaborative development and commercialization of the Oncomine Comprehensive Assay Plus and Determa IO assay, intended for integration with the Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was founded in 2009 and maintains its principal office in Irvine, California.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| SILVERMAN LOU | F-InKind | 7,700 | $5.69 | 2026-07-01 |
| Last Andrew J. | F-InKind | 7,700 | $5.69 | 2026-07-01 |
| Arno Andrew | F-InKind | 12,100 | $5.69 | 2026-07-01 |
| SILVERMAN LOU | A-Award | 26,943 | — | 2026-06-11 |
| Last Andrew J. | A-Award | 26,943 | — | 2026-06-11 |